FOSL2 was found to be aberrantly expressed in non-small-cell lung cancer, ovarian cancer, liver cancer, and other malignant tumors and is involved in the growth and metastasis of tumor cells as a prooncogene [54–56]. The gene discussed is FOSL2; the disease is neoplasm.